Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.
about
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cellsVaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?Proteome sampling by the HLA class I antigen processing pathwayDeletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switchingVaccinomics: current findings, challenges and novel approaches for vaccine developmentVaccinomics and a new paradigm for the development of preventive vaccines against viral infections.T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.How much of virus-specific CD8 T cell reactivity is detected with a peptide pool when compared to individual peptides?Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.Discovering naturally processed antigenic determinants that confer protective T cell immunity.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.Vaccination and the TAP-independent antigen processing pathways.Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!Defending against smallpox: a focus on vaccines.Dana-Farber repository for machine learning in immunology.Personalized vaccinology: A review.Deciphering the human antigenome.Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency.Vaccinomics, predictive vaccinology and the future of vaccine development.
P2860
Q24294775-4DEC3794-9A81-49A2-ADE5-841B037330FBQ34126261-9A9584E6-148C-4C4B-9761-9ED7E9B72F38Q34276972-9BE9F9E8-7602-46C8-BD4A-203CCC7B6E0FQ34810232-C06ED0AB-B897-4CE8-B378-0D88DBE1D04EQ35176899-AFB7E8C3-FBAD-4C80-912E-AD40C1DEC19BQ35193959-FEAE2F77-8511-442C-89AF-85CBA7DB5FA8Q35206861-E0383E5E-3B1A-4632-A86B-6C064F78379BQ35641132-83D37151-2BBE-4E87-80C3-D73FF42999CBQ36432686-54D7DE75-7830-49A0-9B61-9C5F4AE49092Q36533322-13D508BF-C2F5-4784-A8C8-E6FC16F6108CQ36793499-A7581639-B676-4001-B86E-75412D730427Q37119456-6966D53F-B6FE-4500-A52C-CFE8FB183C08Q37748492-17E59A37-8663-4C4A-ACA8-DB5F429C7423Q38140044-36B053A2-3785-46D8-9AE8-4BC95239FC87Q38347244-FC4CE54C-DE14-40AA-A350-44E64A0EF435Q38799357-1D5CBD02-257C-40A3-866F-9CFF114D73B7Q40086895-E1ED1CF5-45D0-435B-9F6B-F8D360B40B9DQ40107665-A966900A-3AB4-4B66-A9C5-70510BD96052Q40885928-479037B4-D561-42E5-8263-5436D1F5E61EQ41325257-D3185991-2E4A-43C0-869C-87CE78B11A15Q51772775-FC506E71-633B-42AF-B533-1C5FA3D485EB
P2860
Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discovery of naturally process ...... metry for vaccine development.
@en
Discovery of naturally process ...... metry for vaccine development.
@nl
type
label
Discovery of naturally process ...... metry for vaccine development.
@en
Discovery of naturally process ...... metry for vaccine development.
@nl
prefLabel
Discovery of naturally process ...... metry for vaccine development.
@en
Discovery of naturally process ...... metry for vaccine development.
@nl
P2093
P2860
P1433
P1476
Discovery of naturally process ...... metry for vaccine development.
@en
P2093
Christopher J Mason
H Robert Bergen
Kenneth L Johnson
P2860
P356
10.1016/J.VACCINE.2009.09.126
P407
P577
2009-10-12T00:00:00Z